BSX Stock Surges As It Looks To Enter A Nearly $8 Billion Market
Boston Scientific (BSX) is likely to win Food and Drug Administration approval for a new method of treating abnormal heartbeats, analysts said Monday. BSX stock surged on news. X The company tested a method known as pulsed field ablation in…